跳至主要内容
临床试验/NCT01664689
NCT01664689已完成不适用

Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification

Iladevi Cataract and IOL Research Center2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Corneal clarity on postoperative day 1

研究概览

简要总结

Ophthalmic Viscosurgical Devices (OVDs) play a crucial role during phacoemulsification, by providing endothelial protection, maintaining space, as well as facilitating surgical maneuvers, including IOL implantation. Equally important is the ease of use, good visualisation and easy removal of the OVD from the eye. Currently, 3 popularly used OVDs as a single injection sufficing for surgery are: Healon 5, DiscoVisc, and Celoftal (2% hydroxypropylmethylcellulose). Whereas, there are studies showing efficacy of each of these in clinical scenarios, there is no randomized trial comparing intraoperative performance and postoperative outcomes. The aim of this study was to compare intraoperative performance and postoperative outcomes following microcoaxial phacoemulsification when using one of the three OVDs

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age related, uncomplicated senile cataracts

排除标准

  • presence of glaucoma,
  • shallow anterior chamber (ACD < 2.1mm),
  • pupillary dilatation < 6mm,
  • extremely dense cataracts,
  • posterior polar cataract,
  • subluxated cataract,
  • white mature cataract,
  • diabetic retinopathy,
  • high myopia (defined as AL > 25mm),
  • uveitis, or
  • previous ocular trauma/surgery.

结局指标

主要结局

Corneal clarity on postoperative day 1

时间窗: postoperative day 1

次要结局

  • Central corneal thickness on postoperative day 1 and week 1(day 1 and week 1)

研究者

发起方
Iladevi Cataract and IOL Research Center
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验